Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-12-004662

Options or other derivatives

  • Sr. VP, Drug Development acquired 63,036 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Koya Keizo · Sr. VP, Drug Development

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2012-03-06 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +63,036 63,036 D
Loading xslF345X03/edgar.xml…